Knowledge of genomic testing among early-stage breast cancer patients.
Richman, Alice R
Tzeng, Janice P
Carey, Lisa A
Retèl, Valesca P
Brewer, Noel T
Psycho-oncology 2011 Jan; 20(1): 28-35
Genomic recurrence risk test results now inform clinical decisions about adjuvant treatment for women with early-stage breast cancer. We sought to understand patients' knowledge of these tests and correlates of their knowledge.
Permanent LinkFind Full Text at Georgetown University Library
Full Text from Publisher
Showing items related by title, author, creator and subject.
Predictive Value of Estrogen Receptor Status as Assessed by Ligand-Binding Assay in Patients With Early-Stage Breast Cancer Treated With Breast Conserving Surgery and Radiation Therapy Takei, Hiroyuki; Horiguchi, Jun; Maemura, Michio; Koibuchi, Yukio; Oyama, Tetsunari; Yokoe, Takao; Iino, Yuichi; Morishita, Yasuo (2002-03)
Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer Peters, Nikki; Domcheck, Susan M.; Rose, Abigail; Polis, Rachael; Stopfer, Jill; Armstrong, Katrina (2005-03)
Bach, Peter B.; Cramer, Laura D.; Warren, Joan L.; Begg, Colin B. (1999-10-14)BACKGROUND: If discovered at an early stage, non-small-cell lung cancer is potentially curable by surgical resection. However, two disparities have been noted between black patients and white patients with this disease. Blacks ...